In a bid to keep itself afloat into the back half of 2026, gene therapy specialist Tenaya Therapeutics on March 27 kicked off a restructuring initiative that will involve the termination of 30% to 40% of its staff.
In a bid to keep itself afloat into the back half of 2026, gene therapy specialist Tenaya Therapeutics on March 27 kicked off a restructuring initiative that will involve the termination of 30% to 40% of its staff.